Trigger Point Injection in Patients With Myofascial Pain Syndrome

Last updated: August 13, 2024
Sponsor: Firat University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Fibromyalgia

Treatment

Ultrasound guided injection

Blinded injection

Clinical Study ID

NCT06555523
2024/03-10
  • Ages 18-65
  • All Genders

Study Summary

This study aims to compare the effectiveness of blinded versus ultrasound-guided trigger point injections into the trapezius muscle in patients with FMS. Seventy-five patients with FMS will participate in this study. They will be randomly assigned to one of two groups: one group received ultrasound-guided trigger point injections, while the other group received blinded trigger point injections. Both groups will follow the same home exercise regimen, which included stretching and posture exercises targeting the trapezius and pectoral muscles. The effectiveness of the treatments was evaluated one month post-treatment. The assessment tools will include the Fibromyalgia Impact Questionnaire (FIQ) for function, the Visual Analog Scale (VAS) for pain, the Beck Anxiety Inventory (Beck-A) for anxiety, and the Neck Disability Questionnaire (NDQ) for neck disability.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients aged 20-60 years who met the 2013 ACR criteria

  • Patients who will be diagnosed with FMS and cervical chronic MAS according to Traveland Simons' criteria

  • Patients who had a palpated tense band in the upper trapezius muscle and at least 1active trigger point

Exclusion

Exclusion Criteria:

  • Patients with a diagnosis of cervical radiculopathy, myelopathy, local or systemicinfection, treatment for MAS in the last 3 months

  • Patients who have symptom duration less than 3 months

  • Patients with pregnancy status, acute or chronic disease that would cause clinicalconfusion at the time of the study

Study Design

Total Participants: 20
Treatment Group(s): 2
Primary Treatment: Ultrasound guided injection
Phase:
Study Start date:
August 20, 2024
Estimated Completion Date:
September 20, 2024

Study Description

The primary objectives in treating Fibromyalgia Syndrome (FMS) are to deactivate trigger points, alleviate pain, and remove factors that exacerbate the condition. Recently, the use of ultrasound (US) has been advocated to reduce potential complications during trigger point injections and to ensure more effective administration of the treatment.This study aims to compare the effectiveness of blinded versus ultrasound-guided trigger point injections into the trapezius muscle in patients with FMS. Seventy-five patients with FMS will participate in this study. They will be randomly assigned to one of two groups: one group received ultrasound-guided trigger point injections, while the other group received blinded trigger point injections. Both groups will follow the same home exercise regimen, which included stretching and posture exercises targeting the trapezius and pectoral muscles. The effectiveness of the treatments was evaluated one month post-treatment. The assessment tools will include the Fibromyalgia Impact Questionnaire (FIQ) for function, the Visual Analog Scale (VAS) for pain, the Beck Anxiety Inventory (Beck-A) for anxiety, and the Neck Disability Questionnaire (NDQ) for neck disability.

Connect with a study center

  • Songul

    Elazığ, 23100
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.